Sonoma Pharmaceuticals, Inc. ( SNOA) - Key Metrics
SNOA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2027Q1 | $1.67 | -$0.09 | -$0.17 | -$0.17 |
| 2026Q4 | $3.15 | -$0.33 | -$0.29 | -$0.31 |
| 2026Q3 | $2.54 | -$0.48 | -$0.45 | -$0.47 |
| 2026Q2 | $3.40 | -$0.32 | -$0.06 | -$0.09 |
| 2026Q1 | $2.45 | -$0.76 | -$1.23 | -$1.29 |
SNOA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2027Q1 | 0% | -3.42 |
| 2026Q4 | 0% | -1.61 |
| 2026Q3 | 0% | -1.90 |
| 2026Q2 | 0% | -3.03 |
| 2026Q1 | 0% | -0.94 |
SNOA
Price: $1.13
52 week price:
Earnings Per Share: -1.22 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 313242
Ebitda: -12.7 millionMarket Capitalization: 5.8 million